Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00122
|
|||||
| Drug Name |
MYO-inositol
|
|||||
| Synonyms |
1D-Chiro-inositol; 1L-Chiro-inositol; 488-59-5; 643-12-9; 6917-35-7; 87-89-8; Allo-inositol; Cocositol; Cyclohexane-1,2,3,4,5,6-hexaol; Cyclohexitol; D-(+)-chiro-Inositol; D-chiro-Inositol; Dambose; Inosital; Inosite; Inositene; Inositina; Iso-inositol; Meat sugar; Mesoinosit; Mesoinosite; Muco-Inositol; Myoinosite; Neo-inositol; Phaseomannite; Phaseomannitol; Quercinitol; Scyllite; Scyllitol; Scyllo-inositol; cis-Inositol; cyclohexane-1,2,3,4,5,6-hexol; epi-Inositol; i-Inositol; inositol; meso-Inositol; mesoinositol
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Polycystic ovary syndrome [ICD11: 5A80.1] | Phase 4 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C6H12O6
|
|||||
| Canonical SMILES |
C1(C(C(C(C(C1O)O)O)O)O)O
|
|||||
| InChI |
InChI=1S/C6H12O6/c7-1-2(8)4(10)6(12)5(11)3(1)9/h1-12H
|
|||||
| InChIKey |
CDAISMWEOUEBRE-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 173524-45-3
|
|||||
| Pharmaceutical Properties | Molecular Weight | 180.16 | Topological Polar Surface Area | 121 | ||
| Heavy Atom Count | 12 | Rotatable Bond Count | 0 | |||
| Hydrogen Bond Donor Count | 6 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
-3.7
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10523934
, 10523935
, 10523936
, 105284
, 105285
, 105291
, 10531552
, 10537350
, 10548140
, 11364489
, 11367051
, 11369613
, 11371925
, 11375023
, 11377775
, 11446130
, 11455636
, 11490868
, 11493007
, 11495409
, 2958
, 3133547
, 3155010
, 3155011
, 3437
, 405648
, 419053
, 474354
, 594439
, 594440
, 606061
, 6332601
, 73813
, 7888419
, 8137917
, 8138252
, 8138293
, 8138294
, 8141702
, 8145718
, 8146839
, 8146881
, 8150849
, 820280
, 822652
, 8408
, 8409
, 841533
, 86405
, 99187
|
|||||
| ChEBI ID |
ChEBI:17268
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | SMIT | Transporter Info | Sodium/myo-inositol cotransporter | Substrate | [2] | |
| SMIT2 | Transporter Info | Sodium/myo-inositol cotransporter 2 | Substrate | [3] | ||
| References | ||||||
| 1 | ClinicalTrials.gov (NCT01540747) Role of Melatonin Supplementation in Follicular Fluid of in Vitro Fertilization (IVF) Patients With Polycystic Ovarian Syndrome | |||||
| 2 | Identification of a novel Na+/myo-inositol cotransporter. J Biol Chem. 2002 Sep 20;277(38):35219-24. | |||||
| 3 | The sodium/glucose cotransport family SLC5. Pflugers Arch. 2004 Feb;447(5):510-8. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.